{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:55:01Z","timestamp":1774353301908,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1475-2875-12-385","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T04:06:00Z","timestamp":1383278760000},"source":"Crossref","is-referenced-by-count":32,"title":["Comparative safety of artemether-lumefantrine and other artemisinin-based combinations in children: a systematic review"],"prefix":"10.1186","volume":"12","author":[{"given":"Oluwaseun","family":"Egunsola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazeem A","family":"Oshikoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,1]]},"reference":[{"key":"2988_CR1","unstructured":"World Health Organization: Malaria.\n                    http:\/\/www.who.int\/mediacentre\/factsheets\/fs094\/en\/\n                    \n                  ,"},{"key":"2988_CR2","volume-title":"Antimalarial drug combination therapy: report of a technical consultation","author":"WHO","year":"2001","unstructured":"WHO: Antimalarial drug combination therapy: report of a technical consultation. 2001, Geneva: World Health Organization,\n                    http:\/\/whqlibdoc.who.int\/hq\/2001\/WHO_CDS_RBM_2001.35.pdf\n                    \n                  ,"},{"issue":"Suppl 1","key":"2988_CR3","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1475-2875-8-S1-S5","volume":"8","author":"M Makanga","year":"2009","unstructured":"Makanga M, Krudsood S: The clinical efficacy of artemether\/lumefantrine (Coartem). Malar J. 2009, 8 (Suppl 1): S5-10.1186\/1475-2875-8-S1-S5.","journal-title":"Malar J"},{"key":"2988_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1517\/14656566.8.1.75","volume":"8","author":"G Kokwaro","year":"2007","unstructured":"Kokwaro G, Mwai L, Nzila A: Artemether\/lumefantrine in the treatment of uncomplicated falciparum malaria. Expert Opin Pharmacother. 2007, 8: 75-94. 10.1517\/14656566.8.1.75.","journal-title":"Expert Opin Pharmacother"},{"key":"2988_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1046\/j.1365-2125.1998.00830.x","volume":"46","author":"F Ezzet","year":"1998","unstructured":"Ezzet F, Mull R, Karbwang J: Population pharmacokinetics and therapeutic response of CGP 56697(artemether\u2009+\u2009benflumetol) in malaria patients. Br J Clin Pharmacol. 1998, 46: 553-561.","journal-title":"Br J Clin Pharmacol"},{"key":"2988_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2165\/00044011-199918060-00006","volume":"18","author":"G Lefevre","year":"1999","unstructured":"Lefevre G, Thomsen MS: Clinical pharmacokinetics of artemether and lumefantrine (Riamet\u00ae). Clin Drug Investig. 1999, 18: 467-480. 10.2165\/00044011-199918060-00006.","journal-title":"Clin Drug Investig"},{"key":"2988_CR7","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1475-2875-8-S1-S3","volume":"8","author":"ZG Premji","year":"2009","unstructured":"Premji ZG: Coartem\u00ae: the journey to the clinic. Malar J. 2009, 8: S3-","journal-title":"Malar J"},{"key":"2988_CR8","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1475-2875-8-S1-S6","volume":"8","author":"C Falade","year":"2009","unstructured":"Falade C, Manyando C: Safety profile of Coartem: the evidence base. Malar J. 2009, 8: S6-","journal-title":"Malar J"},{"key":"2988_CR9","unstructured":"Artemether-lumefantrine full prescribing information. [\n                    http:\/\/www.pharma.us.novartis.com\/cs\/www.pharma.us.novartis.com\/product\/pi\/pdf\/coartem.pdf\n                    \n                  ]"},{"key":"2988_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0035-9203(00)90126-3","volume":"94","author":"R Bakshi","year":"2000","unstructured":"Bakshi R, Hermeling-Fritz I, Gathmann I, Alteri E: An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug. Trans R Soc Trop Med Hyg. 2000, 94: 419-424. 10.1016\/S0035-9203(00)90126-3.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"2988_CR11","unstructured":"Cochrane bias method group: Assessing risk of bias in included studies.\n                    http:\/\/bmg.cochrane.org\/assessing-risk-bias-included-studies\n                    \n                  ,"},{"key":"2988_CR12","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/adc.2009.175562","volume":"95","author":"TW de Vries","year":"2010","unstructured":"de Vries TW, van Roon EN: Low quality of reporting adverse drug reactions in paediatric randomised controlled trials. Arch Dis Child. 2010, 95: 1023-1026. 10.1136\/adc.2009.175562.","journal-title":"Arch Dis Child"},{"key":"2988_CR13","first-page":"360","volume":"37","author":"AJ Viera","year":"2005","unstructured":"Viera AJ, Garrett JM: Understanding interobserver agreement: the kappa statistic. Fam Med. 2005, 37: 360-363.","journal-title":"Fam Med"},{"key":"2988_CR14","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N: Meta-analysis in clinical trials. Contr Clin Trials. 1986, 7: 177-188. 10.1016\/0197-2456(86)90046-2.","journal-title":"Contr Clin Trials"},{"key":"2988_CR15","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1086\/647946","volume":"49","author":"E Arinaitwe","year":"2009","unstructured":"Arinaitwe E, Sandison TG, Wanzira H, Kakuru A, Homsy J, Kalamya J, Kamya MR, Vora N, Greenhouse B, Rosenthal PJ, Tappero J, Dorsey G: Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clin Infect Dis. 2009, 49: 1629-1637. 10.1086\/647946.","journal-title":"Clin Infect Dis"},{"key":"2988_CR16","doi-asserted-by":"publisher","first-page":"e7871","DOI":"10.1371\/journal.pone.0007871","volume":"4","author":"Q Bassat","year":"2009","unstructured":"Bassat Q, Mulenga M, Tinto H, Piola P, Borrmann S, Men\u00e9ndez C, Nambozi M, Val\u00e9a I, Nabasumba C, Sasi P, Bacchieri A, Corsi M, Ubben D, Talisuna A, D\u2019Alessandro U: Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial. PLoS One. 2009, 4: e7871-10.1371\/journal.pone.0007871.","journal-title":"PLoS One"},{"key":"2988_CR17","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1371\/journal.pctr.0020020","volume":"2","author":"MR Kamya","year":"2007","unstructured":"Kamya MR, Yeka A, Bukirwa H, Lugemwa M, Rwakimari JB, Staedke SG, Talisuna AO, Greenhouse B, Nosten F, Rosenthal PJ, Wabwire-Mangen F, Dorsey G: Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. PLoS Clin Trials. 2007, 2: e20-10.1371\/journal.pctr.0020020.","journal-title":"PLoS Clin Trials"},{"key":"2988_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/1475-2875-8-272","volume":"8","author":"S Katrak","year":"2009","unstructured":"Katrak S, Gasasira A, Arinaitwe E, Kakuru A, Wanzira H, Bigira V, Sandison TG, Homsy J, Tappero JW, Kamya MR, Dorsey G: Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children. Malar J. 2009, 8: 272-10.1186\/1475-2875-8-272.","journal-title":"Malar J"},{"key":"2988_CR19","doi-asserted-by":"publisher","first-page":"e2390","DOI":"10.1371\/journal.pone.0002390","volume":"3","author":"A Yeka","year":"2008","unstructured":"Yeka A, Dorsey G, Kamya MR, Talisuna A, Lugemwa M, Rwakimari JB, Staedke SG, Rosenthal PJ, Wabwire-Mangen F, Bukirwa H: Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS One. 2008, 3: e2390-10.1371\/journal.pone.0002390.","journal-title":"PLoS One"},{"key":"2988_CR20","doi-asserted-by":"publisher","first-page":"e1001119","DOI":"10.1371\/journal.pmed.1001119","volume":"8","author":"Four Artemisinin-Based Combinations (4ABC) Study Group","year":"2011","unstructured":"Four Artemisinin-Based Combinations (4ABC) Study Group: A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomized trial. PLoS Med. 2011, 8: e1001119-10.1371\/journal.pmed.1001119.","journal-title":"PLoS Med"},{"key":"2988_CR21","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1086\/522985","volume":"45","author":"I Zongo","year":"2007","unstructured":"Zongo I, Dorsey G, Rouamba N, Dokomajilar C, S\u00e9r\u00e9 Y, Rosenthal PJ, Ou\u00e9draogo JB: Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Clin Infect Dis. 2007, 45: 1453-1461. 10.1086\/522985.","journal-title":"Clin Infect Dis"},{"key":"2988_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1475-2875-10-50","volume":"10","author":"M Nambozi","year":"2011","unstructured":"Nambozi M, Van Geertruyden JP, Hachizovu S, Chaponda M, Mukwamataba D, Mulenga M, Ubben D, D\u2019Alessandro U: Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children. Malar J. 2011, 10: 50-10.1186\/1475-2875-10-50.","journal-title":"Malar J"},{"key":"2988_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.4269\/ajtmh.2010.10-0158","volume":"83","author":"D Creek","year":"2010","unstructured":"Creek D, Bigira V, Arinaitwe E, Wanzira H, Kakuru A, Tappero J, Kamya MR, Dorsey G, Sandison TG: Increased risk of early vomiting among infants and young children treated with dihydroartemisinin-piperaquine compared with artemether-lumefantrine for uncomplicated malaria. Am J Trop Med Hyg. 2010, 83: 873-875. 10.4269\/ajtmh.2010.10-0158.","journal-title":"Am J Trop Med Hyg"},{"key":"2988_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1475-2875-7-237","volume":"7","author":"PF Mens","year":"2008","unstructured":"Mens PF, Sawa P, van Amsterdam SM, Versteeg I, Omar SA, Schallig HD, Kager PA: A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya. Malar J. 2008, 7: 237-10.1186\/1475-2875-7-237.","journal-title":"Malar J"},{"key":"2988_CR25","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0804915","volume":"359","author":"HA Karunajeewa","year":"2008","unstructured":"Karunajeewa HA, Mueller I, Senn M, Lin E, Law I, Gomorrai PS, Oa O, Griffin S, Kotab K, Suano P, Tarongka N, Ura A, Lautu D, Page-Sharp M, Wong R, Salman S, Siba P, Ilett KF, Davis TM: A trial of combination antimalarial therapies in children from Papua New Guinea. N Engl J Med. 2008, 359: 2545-2557. 10.1056\/NEJMoa0804915.","journal-title":"N Engl J Med"},{"key":"2988_CR26","doi-asserted-by":"publisher","first-page":"e2530","DOI":"10.1371\/journal.pone.0002530","volume":"3","author":"S Owusu-Agyei","year":"2008","unstructured":"Owusu-Agyei S, Asante KP, Owusu R, Adjuik M, Amenga-Etego S, Dosoo DK, Gyapong J, Greenwood B, Chandramohan D: An open label, randomised trial of artesunate + amodiaquine, artesunate + chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria. PLoS One. 2008, 3: e2530-10.1371\/journal.pone.0002530.","journal-title":"PLoS One"},{"key":"2988_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/1475-2875-7-127","volume":"7","author":"GO Adjei","year":"2008","unstructured":"Adjei GO, Kurtzhals JA, Rodrigues OP, Alifrangis M, Hoegberg LC, Kitcher ED, Badoe EV, Lamptey R, Goka BQ: Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Malar J. 2008, 7: 127-10.1186\/1475-2875-7-127.","journal-title":"Malar J"},{"key":"2988_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/1475-2875-9-335","volume":"9","author":"OS Michael","year":"2010","unstructured":"Michael OS, Gbotosho GO, Folarin OA, Okuboyejo T, Sowunmi A, Oduola AM, Happi CT: Early variations in Plasmodium falciparum dynamics in Nigerian children after treatment with two artemisinin-based combinations: implications on delayed parasite clearance. Malar J. 2010, 9: 335-10.1186\/1475-2875-9-335.","journal-title":"Malar J"},{"key":"2988_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1086\/599378","volume":"200","author":"JF Faucher","year":"2009","unstructured":"Faucher JF, Aubouy A, Adeothy A, Cottrell G, Doritchamou J, Gourmel B, Houz\u00e9 P, Kossou H, Amedome H, Massougbodji A, Cot M, Deloron P: Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated Plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial. J Infect Dis. 2009, 200: 57-65. 10.1086\/599378.","journal-title":"J Infect Dis"},{"key":"2988_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/1475-2875-7-261","volume":"7","author":"R Kobbe","year":"2008","unstructured":"Kobbe R, Klein P, Adjei S, Amemasor S, Thompson WN, Heidemann H, Nielsen MV, Vohwinkel J, Hogan B, Kreuels B, B\u00fchrlen M, Loag W, Ansong D, May J: A randomized trial on effectiveness of artemether-lumefantrine versus artesunate plus amodiaquine for unsupervised treatment of uncomplicated Plasmodium falciparum malaria in Ghanaian children. Malar J. 2008, 7: 261-10.1186\/1475-2875-7-261.","journal-title":"Malar J"},{"key":"2988_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1475-2875-7-106","volume":"7","author":"C Maiteki-Sebuguzi","year":"2008","unstructured":"Maiteki-Sebuguzi C, Jagannathan P, Yau VM, Clark TD, Njama-Meya D, Nzarubara B, Talisuna AO, Kamya MR, Rosenthal PJ, Dorsey G, Staedke SG: Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children. Malar J. 2008, 7: 106-10.1186\/1475-2875-7-106.","journal-title":"Malar J"},{"key":"2988_CR32","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1371\/journal.pctr.0010007","volume":"1","author":"H Bukirwa","year":"2006","unstructured":"Bukirwa H, Yeka A, Kamya MR, Talisuna A, Banek K, Bakyaita N, Rwakimari JB, Rosenthal PJ, Wabwire-Mangen F, Dorsey G, Staedke SG: Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin Trials. 2006, 1: e7-10.1371\/journal.pctr.0010007.","journal-title":"PLoS Clin Trials"},{"key":"2988_CR33","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1365-3156.2008.02043.x","volume":"13","author":"CO Falade","year":"2008","unstructured":"Falade CO, Ogundele AO, Yusuf BO, Ademowo OG, Ladipo SM: High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria. Trop Med Int Health. 2008, 13: 635-643. 10.1111\/j.1365-3156.2008.02043.x.","journal-title":"Trop Med Int Health"},{"key":"2988_CR34","doi-asserted-by":"publisher","first-page":"813","DOI":"10.4269\/ajtmh.2011.10-0582","volume":"84","author":"GO Gbotosho","year":"2011","unstructured":"Gbotosho GO, Sowunmi A, Okuboyejo TM, Happi CT, Folarin OA, Michael OS, Adewoye EO: Therapeutic efficacy and effects of artemether-lumefantrine and artesunate-amodiaquine coformulated or copackaged on malaria-associated anemia in children with uncomplicated Plasmodium falciparum malaria in Southwest Nigeria. Am J Trop Med Hyg. 2011, 84: 813-819. 10.4269\/ajtmh.2011.10-0582.","journal-title":"Am J Trop Med Hyg"},{"key":"2988_CR35","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/S0140-6736(05)66417-3","volume":"365","author":"TK Mutabingwa","year":"2005","unstructured":"Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, Greenwood BM, Whitty CJ: Amodiaquine alone, amodiaquine\u2009+\u2009sulfadoxine-pyrimethamine, amodiaquine\u2009+\u2009artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet. 2005, 365: 1474-1480. 10.1016\/S0140-6736(05)66417-3.","journal-title":"Lancet"},{"key":"2988_CR36","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/444460","volume":"41","author":"A M\u00e5rtensson","year":"2005","unstructured":"M\u00e5rtensson A, Str\u00f6mberg J, Sisowath C, Msellem MI, Gil JP, Montgomery SM, Olliaro P, Ali AS, Bj\u00f6rkman A: Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Clin Infect Dis. 2005, 41: 1079-1106. 10.1086\/444460.","journal-title":"Clin Infect Dis"},{"key":"2988_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1475-2875-5-43","volume":"5","author":"M Meremikwu","year":"2006","unstructured":"Meremikwu M, Alaribe A, Ejemot R, Oyo-Ita A, Ekenjoku J, Nwachukwu C, Ordu D, Ezedinachi E: Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial. Malar J. 2006, 5: 43-10.1186\/1475-2875-5-43.","journal-title":"Malar J"},{"key":"2988_CR38","doi-asserted-by":"publisher","first-page":"e6682","DOI":"10.1371\/journal.pone.0006682","volume":"4","author":"Z Premji","year":"2009","unstructured":"Premji Z, Umeh RE, Owusu-Agyei S, Esamai F, Ezedinachi EU, Oguche S, Borrmann S, Sowunmi A, Duparc S, Kirby PL, Pamba A, Kellam L, Guiguemd\u00e9 R, Greenwood B, Ward SA, Winstanley PA: Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria. PLoS One. 2009, 4: e6682-10.1371\/journal.pone.0006682.","journal-title":"PLoS One"},{"key":"2988_CR39","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1365-3156.2010.02701.x","volume":"16","author":"OA Toure","year":"2011","unstructured":"Toure OA, Kouame MG, Didier YJ, Berenger AA, Djerea K, Genevieve GO, Penali LK: Artesunate\/mefloquine paediatric formulation vs. artemether\/lumefantrine for the treatment of uncomplicated Plasmodium falciparum in Anonkoua kout\u00e9, C\u00f4te d\u2019Ivoire. Trop Med Int Health. 2011, 16: 290-297. 10.1111\/j.1365-3156.2010.02701.x.","journal-title":"Trop Med Int Health"},{"key":"2988_CR40","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4269\/ajtmh.2010.09-0265","volume":"82","author":"B Faye","year":"2010","unstructured":"Faye B, Ndiaye JL, Tine R, Sylla K, Gueye A, L\u00f4 AC, Gaye O: A randomized trial of artesunate mefloquine versus artemether lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Senegalese children. Am J Trop Med Hyg. 2010, 82: 140-144. 10.4269\/ajtmh.2010.09-0265.","journal-title":"Am J Trop Med Hyg"},{"key":"2988_CR41","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1086\/605635","volume":"49","author":"A Sykes","year":"2009","unstructured":"Sykes A, Hendriksen I, Mtove G, Mandea V, Mrema H, Rutta B, Mapunda E, Manjurano A, Amos B, Reyburn H, Whitty CJ: Azithromycin plus artesunate versus artemether-lumefantrine for treatment of uncomplicated malaria in Tanzanian children: a randomized, controlled trial. Clin Infect Dis. 2009, 49: 1195-1201. 10.1086\/605635.","journal-title":"Clin Infect Dis"},{"key":"2988_CR42","doi-asserted-by":"crossref","first-page":"991","DOI":"10.4269\/ajtmh.2006.74.991","volume":"74","author":"M Makanga","year":"2006","unstructured":"Makanga M, Premji Z, Falade C, Karbwang J, Mueller EA, Andriano K, Hunt P, De Palacios PI: Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: a pooled analysis of individual patient data. Am J Trop Med Hyg. 2006, 74: 991-998.","journal-title":"Am J Trop Med Hyg"},{"key":"2988_CR43","unstructured":"Update on GSK\u2019s malaria treatments: Dacart and Lapdap.\n                    http:\/\/www.gsk.com\/media\/press-releases\/2008\/update-on-gsks-malaria-treatments-dacart-and-lapdap.html\n                    \n                  ,"},{"key":"2988_CR44","doi-asserted-by":"publisher","first-page":"e1001339","DOI":"10.1371\/journal.pmed.1001339","volume":"9","author":"RE Howes","year":"2012","unstructured":"Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, Hogg MM, Battle KE, Padilla CD, Baird JK, Hay SI: G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012, 9: e1001339-10.1371\/journal.pmed.1001339.","journal-title":"PLoS Med"},{"key":"2988_CR45","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1590\/S0034-89102000000400013","volume":"34","author":"MZ Carrazza","year":"2000","unstructured":"Carrazza MZ, Carrazza FR, Oga S: Clinical and laboratory parameters in dapsone acute intoxication. Rev Saude Publica. 2000, 34: 396-401. 10.1590\/S0034-89102000000400013.","journal-title":"Rev Saude Publica"},{"key":"2988_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1475-2875-11-139","volume":"11","author":"C Van Malderen","year":"2012","unstructured":"Van Malderen C, Van Geertruyden JP, Machevo S, Gonz\u00e1lez R, Bassat Q, Talisuna A, Yeka A, Nabasumba C, Piola P, Daniel A, Turyakira E, Forret P, Van Overmeir C, van Loen H, Robert A, D\u2019 Alessandro U: Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria. Malar J. 2012, 11: 139-10.1186\/1475-2875-11-139.","journal-title":"Malar J"},{"key":"2988_CR47","unstructured":"FDA clears genetic lab test for warfarin Sensitivity.\n                    http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/2007\/ucm108984.htm\n                    \n                  ,"},{"key":"2988_CR48","unstructured":"FDA approves Erbitux for colorectal cancer.\n                    http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/2004\/ucm108244.htm\n                    \n                  ,"},{"key":"2988_CR49","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1086\/424512","volume":"39","author":"M Mayxay","year":"2004","unstructured":"Mayxay M, Khanthavong M, Lindeg\u00e5rdh N, Keola S, Barends M, Pongvongsa T, Yapom R, Annerberg A, Phompida S, Phetsouvanh R, White NJ, Newton PN: Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People\u2019s Democratic Republic. Clin Infect Dis. 2004, 39: 1139-1147. 10.1086\/424512.","journal-title":"Clin Infect Dis"},{"key":"2988_CR50","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/1475-2875-10-292","volume":"10","author":"P Schlagenhauf","year":"2011","unstructured":"Schlagenhauf P, Adamcova M, Regep L, Schaerer MT, Bansod S, Rhein HG: Use of mefloquine in children - a review of dosage, pharmacokinetics and tolerability data. Malar J. 2011, 10: 292-10.1186\/1475-2875-10-292.","journal-title":"Malar J"},{"key":"2988_CR51","unstructured":"Lariam (mefloquine hydrochloride) 250 mg tablets: Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER). 2009,\n                    http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/ucm181182.htm\n                    \n                  ,"},{"key":"2988_CR52","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/1475-2875-7-172","volume":"7","author":"PU Agomo","year":"2008","unstructured":"Agomo PU, Meremikwu MM, Watila IM, Omalu IJ, Odey FA, Oguche S, Ezeiru VI, Aina OO: Efficacy, safety and tolerability of artesunate-mefloquine in the treatment of uncomplicated Plasmodium falciparum malaria in four geographic zones of Nigeria. Malar J. 2008, 7: 172-10.1186\/1475-2875-7-172.","journal-title":"Malar J"},{"key":"2988_CR53","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1136\/adc.2009.165902","volume":"95","author":"M Anderson","year":"2011","unstructured":"Anderson M, Choonara I: A systematic review of safety monitoring and drug toxicity in published randomized controlled trials of antiepileptic drugs in children over a 10-year period. Arch Dis Child. 2011, 95: 731-738.","journal-title":"Arch Dis Child"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-12-385.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1475-2875-12-385\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2875-12-385.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T19:44:32Z","timestamp":1548099872000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/1475-2875-12-385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2988"],"URL":"https:\/\/doi.org\/10.1186\/1475-2875-12-385","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,1]]},"article-number":"385"}}